BREAKING NEWS: CMS Announces Coverage Change to Allow Use of CGM Smart Phone Applications

In an important advocacy victory for our members and their patients, we are encouraged to see that Medicare beneficiaries will be able to use smart phone applications in conjunction with their continuous glucose monitors. Our members and staff have been calling for access to this important safety net, which can help protect patients who experience hypoglycemic events.

We and other Diabetes Advocacy Alliance members — including the American Diabetes Association, the Pediatric Endocrine Society, the American Association of Diabetes Educators, the National Federation for the Blind and the American Association of Clinical Endocrinologists—raised the need for this policy change in a meeting with officials from the U.S. Department of Health and Human Services June 6, just days before the Centers for Medicare and Medicaid Services announced the decision.

You may also like

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

  • Endocrine Society Continues Global EDC Advocacy; EU Election Results Leaves Outcomes for EDC Legislation Uncertain  

    On June 17, the Endocrine Society joined delegations from dozens of countries gathered in Geneva, Switzerland, for the third session of an ad hoc open-ended working group (OEWG) convened under the United Nations Environment Programme (UNEP) to develop proposals to establish a new science policy panel charged with helping to inform governments, companies, farmers and…

Find more in